Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer
出版年份 2023 全文链接
标题
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer
作者
关键词
-
出版物
Breast Cancer
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-09
DOI
10.1007/s12282-023-01509-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database
- (2022) Jiwoong Jung et al. Breast Cancer
- Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer–Specific Mortality Among US Women
- (2021) Kent F. Hoskins et al. JAMA Oncology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2− Early Breast Cancer
- (2021) Mi Jeong Kwon et al. Frontiers in Oncology
- Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer
- (2021) Fumine Tsukamoto et al. BMC CANCER
- Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study
- (2020) Emily Heer et al. Lancet Global Health
- Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial
- (2020) Kathy S Albain et al. JNCI-Journal of the National Cancer Institute
- Prediction of Distant Recurrence using EndoPredict among Women with ER+, HER2- Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only
- (2019) Martin Filipits et al. CLINICAL CANCER RESEARCH
- Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians versus the US Population
- (2019) Ching-Hung Lin et al. JNCI-Journal of the National Cancer Institute
- Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
- (2019) Mi Jeong Kwon et al. Frontiers in Oncology
- Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast Cancer
- (2018) Ivana Sestak et al. JAMA Oncology
- BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer
- (2018) Mi Jeong Kwon et al. PLoS One
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer
- (2017) Gyungyub Gong et al. Scientific Reports
- Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor–Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14
- (2016) Norman Wolmark et al. JOURNAL OF CLINICAL ONCOLOGY
- Application of a 70-Gene Expression Profile to Japanese Breast Cancer Patients
- (2015) Hideo Shimizu et al. Breast Care
- Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50 Risk of Recurrence Score
- (2015) Ivana Sestak et al. JOURNAL OF CLINICAL ONCOLOGY
- The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer
- (2014) Martin Filipits et al. CLINICAL CANCER RESEARCH
- The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients
- (2013) P Dubsky et al. BRITISH JOURNAL OF CANCER
- Prospective Study of the Effect of the 21-Gene Assay on Adjuvant Clinical Decision-Making in Japanese Women With Estrogen Receptor-Positive, Node-Negative, and Node-Positive Breast Cancer
- (2013) Hideko Yamauchi et al. Clinical Breast Cancer
- Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population
- (2013) Dennis C Sgroi et al. LANCET ONCOLOGY
- Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
- (2011) Pilar Eroles et al. CANCER TREATMENT REVIEWS
- Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects
- (2011) Ismail Jatoi et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients
- (2010) Yasuto Naoi et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population
- (2010) Masakazu Toi et al. CANCER
- Clinical Utility of the 70-gene MammaPrint Profile in a Japanese Population
- (2010) M. Ishitobi et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started